- Maviret is the brand name of a pill containing two anti-HCV drugs - glecaprevir and pibrentasvir. Maviret has been approved in Canada, the U.S. and the European ...
- Researchers in the Lombardy region in northwest Italy collected data from 30 clinics in the area where people with chronic hepatitis C virus (HCV) used Maviret ...
- In a study called Expedition-5, researchers enrolled 110 participants who had moderate to severe kidney injury and chronic HCV infection. Participants were ...
- TreatmentUpdate has always reported on the experimental use of treatments for HCV and other conditions. For information about how major HCV treatments are used ...
- CATIE NewsAn Ontario study examined issues facing post-exposure prophylaxis (PEP) users.. At least one psychosocial issue was identified in 74% of participants.. ...
- CATIE NewsOntario researchers analysed outcomes of patients hospitalized for mental health issues.. Study compared HIV-positive and HIV-negative patients 90 days after ...
- This fact sheet is intended to give service providers a background on trauma-informed care.
- The Pan-Canadian STBBI Framework for Action provides a roadmap for collaborative and complementary actions to reduce the impact of STBBI in Canada and to contribute to the global efforts to end AIDS…
- Production of this publication has been made possible through financial contributions from the Public Health Agency of Canada. We would like to thank the ...
- PositiveLinks is a mobile intervention for people with HIV, which includes use of a custom smartphone app that can be tailored to the needs and preferences of participants.
- WebinarA webinar in partnership with Positive Living B.C. Peer health navigation is a person-centred approach to guide, connect, refer, educate and accompany people ...
- Prevention in FocusWe take a look at the increasingly important roles of supervised consumption services and overdose prevention sites in Canada’s current harm reduction response.